Search, Evaluation & Investment Panel: Understanding the Role of In Vivo Therapeutic in Shifting Investor & Pharma Strategies
- Assessing how investors and pharma teams are integrating in vivo approaches into evolving pipeline and portfolio strategies
- Identifying the evidence and value inflection points shaping investment decisions for in vivo cell and gene therapy programs
- Aligning milestones, data packages and deal structures with shifting search, evaluation and investment priorities across the sector